DEVELOPMENT AND OPTIMIZATION OF ORODISPERSIBLE TABLETS OF SEROTONIN HYDROCHLORIDE

DEVELOPMENT AND OPTIMIZATION OF ORODISPERSIBLE TABLETS OF SEROTONIN HYDROCHLORIDE

Pratik Swarup Das ^* and Puja Saha

Department of Pharmaceutics Pharmacy Institute, Noida Institute of Engineering and Technology, Greater Noida - 201306, Uttar Pradesh, India.

ABSTRACT: The aim of the present work is to develop the formulation the orodispersible tablets of Serotonin hydrochloride. The tablets were prepared by direct compression technique using microcrystalline cellulose (MCC) as directly compressible diluents. Superdisintegrants such as Croscarmellulose sodium (CCS) Sodium starch glycolate (SSG) and Crospovidone were used. Method: Using different concentrations of superdisintegrants seven formulations were made and further investigated. The prepared powder mixtures were subjected to both preformulation and physical evaluation studies, and further post compression evaluation parameters including tablet hardness, friability, disintegration time and in-vitro drug release. Results: The pre-compression studies revealed that all formulations were found to be of good flowability. Tablet hardness and friability revealed good mechanical strength. Conclusion: After evaluating all the formulations it has been revealed that the tablets exhibited acceptable properties. According to the present study, it was found that tablets of batch F4 (blend containing CCS & crospovidone (15mg) showed better disintegrating property as well as % drug release (98.78% within 40 min).

Orodispersible tablet, Serotonin Hydrochloride, Superdisintegrants, Formulations, flowability

INTRODUCTION: Orodispersible tablets have received ever-increasing demand throughout the last decade and therefore the field has become a quickly growing area within the pharmaceutical industry ¹. Recent advances in novel drug delivery (NDDS) aims to boost safety and efficaciousness of drug molecule by formulating a convenient dosage form for easy administration and to attain higher   patient compliance ². Orodispersible tablets are uncoated or film - coated tablets meant to be distributed in water before administration giving a homogenous dispersion.

The right selection of disintegrates and its consistency of performance are of crucial importance to the formulation development of such tablets. Orodispersible tablets are well administered for the pediatric, dysphasic patients, unstable, uncooperative and ill patients, those with conditions of nausea, sudden episodes of allergic attack or coughing ³. The basic approaches to develop dispersible tablet include maximising the porous structure of the tablet matrix, incorporating the suitable disintegrating agent and using extremely water soluble excipients in the formulation ⁴.

Serotonin hydrochlorine is a monoamine that is biochemically derived from tryptophane and created in serotonergic neurons within the central nervous system and in enterochromaffin cells within the digestive tract ⁵. 5-hydroxytryptamine is very important for regulation of mood, sleep, vomiting, sexuality, and appetency. Low levels of 5-hydroxytryptamine are related to many disorders, as well as depression, migraines, manic-depressive psychosis, and anxiety. Its actions are terminated primarily via uptake of 5-hydroxytryptamine from the junction. Monoamine neurotransmitter uptake may be suppressed with methylenedioxy-methamphetamine, cocaine, tricyclic antidepressant antidepressants, and selective 5-hydroxytryptamine re-uptake inhibitors ⁶.

MATERIALS AND METHODS:

Preparation of Serotonin Hydrochloride Orodispersible Tablets: ^{7 – 9} All the ingredients were weighed as specified in the formula Table 1. Drug diluents, lubricant and disintegrants were passed through sieve # 80. The drug was first mixed homogeneously with diluents and disintegrant in a mortar and pestle and required degree of fineness was attained. Finally magnesium stearate were added and mixed. Different formulations (F1 to F7) were prepared by direct compression technique. The resultant blends after micromeritic evaluations were directly compressed using 8 mm flat punches with tablet weight 220 mg in a single punch rotatory machine. A batch size of 20 tablets was prepared in each formulation.

TABLE 1: FORMULATION OF SEROTONIN HYDROCHLORIDE TABLETS CONTAINING DIFFERENT CONCENTRATION OF SUPERDISINTEGRANTS

Precompression Evaluation of Powder Blend: Angle of Repose (θ): The frictional force in a loose powder can be measured by angle of repose. Angle of repose is defined as the maximum angle possible between the surface of a pile of the powder and horizontal plane. It is determined by using fixed funnel method. The granules were poured through a funnel that can be raised vertically until a maximum cone height was obtained. The radius of the heap was measured, as angle of repose was calculated by using formula: ^10-12

θ= tan^-1 (h/r)

Where, θ = Angle of repose

h = Height of pile

r = Radius of the base of pile

Bulk density (Db): It is the ratio of total mass of powder to the bulk volume of powder. Bulk density was determined by pouring the powder into graduated cylinder. The bulk volume and mass of the powder was noted. It is expressed in gm/cc and bulk density was calculated by using formula:

Db = M/Vb

Where, M = Mass of powder

Vb = Bulk volume of the powder

Tapped density (DT): It is the ratio of total mass of powder to the tapped volume of powder. The measuring cylinder containing known mass of powder tapped for a fixed time. The maximum volume occupied in the cylinder and weight of the granules was measured. It is expressed in gm/cc, tapped density can be calculated by using formula:

Dt = M/Vt

Where, Dt = Tapped density

M = Mass of powder

Vt = Tapped volume of the powder

Carr’s Consolidation Index: Specific amount of powder was transferred to measuring cylinder and the initial volume occupied was noted as (Vb) and the content was tapped for 100 times and the volume was noted (Vt). Then calculated the Carr’s consolidation index by using the following formula:

Carr’s consolidation index = (Vt-Vb/Vt) × 100

Where, Vb = Bulk volume

Vt = Tapped volume

Hausner’s Ratio: Hausner’s ratio is an indirect index of ease of powder flow.

Hausner’s ratio can be determined by the following equation:

Hausner’s ratio = TBD / LBD

Where, TBD = Tapped bulk densities

LBD = Loose bulk densities

TABLE 2: PRECOMPRESSION EVALUATION OF DISPERSIBLE TABLET BLEND OF SEROTONIN HYDROCHLORIDE MEAN ± SD N=3

 Post Compression Evaluation of Tablets: ^{13 - 18}

Dispersibility Test: ¹³ Two tablets were placed in 100 ml of distilled water and stirred until completely dispersed. A smooth dispersion is produced, which passes through a sieve screen with a nominal mesh aperture of ASTM#22.

Disintegration Test: ^{13 - 14} One tablet was kept in each tube of the disintegration apparatus, suspended the assembly in the basket containing water and operated with the discs for 4 minutes, unless otherwise stated in the individual monograph. Remove the assembly from the liquid. Dispersible tablet should complete the disintegration within 3 minutes in water temperature 15 ºC to 25 ºC.

% Drug Content Uniformity: Twenty tablets were powdered, and 150 mg equivalent weight of Serotonin hydrochloride in powder was accurately weighed and transferred into a 100 ml volumetric flask. Initially, 50ml of acidic buffer (pH 1.2) was added and shaken for 10 min. Then, the volume was made up to 100 ml with phosphate buffer.

The solution in the volumetric flask was filtered, diluted suitably and analyzed spectrophoto-metrically at 345 nm. The drug content in each tablet was calculated using the standard calibration curve of Serotonin Hydrochloride in pH 1.2.

In-vitro Dissolution Studies: Dissolution studies for all the formulated tablets were carried out using USP paddle method at 75rpm in 900 ml of 0.1 N HCl at 37 ºC as dissolution media. 5 ml aliquot was withdrawn at the specified time intervals and assayed spectrophotometrically at 345 nm. An equal volume of fresh medium, which was prewarmed, was replaced into the dissolution media after each sampling to maintain the constant volume throughout the test.

Thickness, Hardness, Friability and Weight Variation Studies: Tablets from all the seven formulations were evaluated for its various properties like thickness diameter using digital vernier calipers, hardness by using Monsanto hardness tester, friability by using roche friabilator and weight variation by using a electronic balance.

TABLE 3: POST-COMPRESSION EVALUATION OF ORODISPERSIBLE TABLET OF SEROTONIN HYDROCHLORINE

Mean ±SD *n=6, **n=10 and #n=10

RESULTS AND DISCUSSION:

Characterization of Amoxicillin Trihydrate Dispersible Powder Blend: The formulation showed good flow property and compressibility index. Angle of repose ranged from 28º.451-30º.861, Carr’s index ranged from ^{16 - 17}. The LBD and TBD of the prepared granules ranged from 0.42 - 0.45 and 0.51 - 0.55 g/cc respectively, Hausner’s ratio was found to be 1.30 - 1.33. The results of angle of repose indicates good flow property of the granules and the value of Carr’s index further showed support for the flow property. The result were showed in Table 2.

Characterization of Serotonin Hydrochlorine Dispersible Tablet: The tablets with weight of 220mg subjected to quality control tests such as weight variation, Hardness, Friability and Thickness Table 3. All formulation products lied within the pharmacopoeial requirement within ±7.5 for weight variation. The mean values for hardness was within 5.75 - 6.08 kg/cm² and all formulations exhibits friability within the 0.52- 0.68% during the friability determination. The thickness was found in the range of 4.11 - 4.26 mm. The results showed good mechanical strength and had uniformity size of the tablets.

Disintegration Test and Dispersibility Test: Disintegration is the most important characteristic test of dispersible tablet, among the formulation (F4) formulated with croscarmellulose sodium and crospovidone shows excellent disintegration time of 38 sec. All the formulation passed the dispersibility test.

In-vitro Dissolution Study: In formulation F1, F2, F3 were formulated with single superdisintegrants, Croscarmellulose sodium, Crospovidone, Sodium starch glycolate and respectively were used along with the drug, the release of the drug from the F1 and F2 was showed satisfactory result. F3 shows better drug release from the formulation. F4 were formulated with crospovidone and croscarmellulose sodium shows an excellent release of the drug from the formulation. F5 formulated with crospovidone and sodium starch glycolate shows increased drug release.F6 with sodium starch glycolate and croscarmellulose sodium with good release of the drug. The F7 formulated with crospovidone, croscarmellulose sodium and sodium starch glycolate showed satisfactory drug release due to combination of three superdisintegrant agent with low ratio. When comparing to the above formulation, F4 showed excellent drug release. It was considered as an optimized formulation in this work.

FIG. 1: IN-VITRO DISSOLUTION STUDY

CONCLUSION: The present study shows that Serotonin Hydrochlorine Orodispersible tablet dosage form formulated by direct compression technique. The in-vitro study shows formulation F4 is well suited to orodispersible tablet formulation due to the disintegration time of just 38 sec, which is formulated by using superdisintegrents croscarmellulose and crospovidone.

ACKNOWLEDGEMENT: The Authors are thankful to Pharmacy Institute, Noida Institute of Engineering and Technology for providing facilities for the research work.

CONFLICT OF INTEREST: The authors declare that there are no conflicts of interest.

REFERENCES:

1. Patidar A, Mishra P, Main P, Harsoliya S and Agrawal S: A review on-recent advancement in the development of rapid disintegrating tablet. Indian Journal of Life Sciences and Pharma Research. 2011; 1(1): 7-16.
2. Pratik SD and Puja S: A review on computer aided drug design in drug discovery. World journal of pharmacy and pharmaceutical sciences. 2017; 6(7): 279-291.
3. Sandeep D, Kunchu K and Ganesh N: Fast Disintegrating tablets-An emerging trend. 2011; 6(2): 18-22.
4. Fu Y, Yang S, Jeong H, Kimura S and Park K: Orally fast disintegrating tablets: Development, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Sys. 2014; 21: 433-476.
5. Leon L, Herbert A, Lieberman, Joseph L and Kanig: The theory and practice of Pharmacy. Varghese Publishing house, third edition, 1987.
6. British Pharmacopoeia, Volume II, London; Published by HMSO, seventh edition 1988.
7. Bhowmik D, Chiranjib B, Pankaj K and Chandira RM: Fast Dissolving Tablet: An Overview. Journal of Chemical and Pharmaceutical Research. 2015; 1(1): 163-77.
8. Pratik SD and Puja S: A review on Approaches to Achieve Gastric Retention of Floating Drug Delivery System. World journal of pharmacy and pharmaceutical sciences. 2017; 6(7): 415 - 426.
9. Ramesh K, Fasiha S, Hema KB and Vinay KM: Design and evaluation of sustained release matrix tablets of Levofloxacin employing almond gum. Int J Chem Sci. 2014; 12(3): 762-72.
10. Emami J, Tajeddin M and Ahmadi F: Preparation and in-vitro evaluation of sustained release matrix tablets of Flutamide using synthetic and naturally occurring polymers. Iran J Pharm Res. 2010; 7(4): 247-57.
11. Puja S and Pratik SD: Advances in Controlled Release Technology in Pharmaceuticals: A Review. World journal of pharmacy and pharmaceutical sciences. 2017; 6(9): 2070 - 2084.
12. Kamal S, Gautam K and Yash P: Formulation and evaluation of fast dissolving tablets of Amoxicillin Trihydrate using synthetic superdisintegrants. Int J Pharm Bio Sci. 2013; 4(1): 254 - 262.
13. Anupama S, Somashekar N, Tamizhmani T: Recent approach for drug release from matrix tablet: A review. AJRPSB. 2016; 4(3): 122-132.
14. Lachman L, Lieberman HA, Kanig JL: The theory and practice of industrial pharmacy. 3^rd New Delhi: CBS Publishers and Distributors. 293-345.
15. Pratik SD and Puja S. Contact Lenses: A Development towards Ocular Drug Delivery System. World journal of pharmaceutical research. 2017; 6(9): 207-216.
16. Patel P, Roy A, Vinod Kumar SM and Kulkarni M: Formulation and evaluation of colon targeted tablets of ornidazole for the treatment of Amoebiosis. Int J Drug Dev & Res 3: 52-61.
17. Pratik SD, Sushma V and Puja S. Fast Dissolving Tablet Using Solid Dispersion Technique: A Review. Int J Curr Pharm Res. 2017; 9(6): 1- 4.
18. Cooper J and Gunn C: Powder flow and compaction. In: Carter SJ (eds.) Tutorial Pharmacy. CBS Publishers and Distributors, New Delhi, India. 211- 233.
19. Ainley W and Paul JW: Handbook of pharmaceutical excipients part I & II. American pharmaceutical association publication, second edition, 1994.
20. Pratik SD, Puja S, Krishan and Rumpa D: Pharmaceutical Packaging Technology: A Brief Outline. World Journal of Advance Healthcare Research. 2018; 2(1): 16-21.
21. Puja S and Pratik SD: Formulation Development and Evaluation of Buccal Patches of Aceclofenac for Gingivitis. J. Pharm. Dosage Form. & Tech. 2017; 9(4): 163-167.
22. Ganesh K, Suresh R, Jawahar N, Senthil V and Nagasamy VD: Preparation and evaluation of sustained release matrix tablet of Diclofenac sodium using natural polymer. J Pharm Sci & Res. 2010; 2(6): 360-8.
23. Puja S, Sushma V and Pratik SD: Sublingual Drug Delivery: An Indication of Potential Alternative Route. Int J Curr Pharm Res. 2017; 9(6): 5-7.
24. Mitesh N: Cinnarizine or dispersible tablets: A Chitosan based fast mouth dissolving technology. Int J of Pharm Tech research. 2009; 1(4): 1079-91.
25. Pratik SD and Puja S: Design and Characterisation of Transdermal Patches of Phenformin Hydrochloride. Int J Curr Pharm Res. 2017; 9(6): 90-93.
26. Mohapatra A, Parikh RK and Gohel MC: Formulation, development and evaluation of patient friendly dosage forms of Metformin, Part-I: orally disintegrating tablets. AAPS. 2009; 167-171.
27. Bhagwati ST, Hiremath SN and Sreenivas SA: Comparative evaluation of disintegrants by formulating cefixime dispersible tablets, Indian J. Pharm. Edu. Res. 2005; 39: 194-197.
    

    ---

    How to cite this article:

    Das PS and Saha P: Development and optimization of orodispersible tablets of serotonin hydrochloride. Int J Pharm Sci Res 2018; 9(8): 3317-21. doi: 10.13040/IJPSR.0975-8232.9(8).3317-21.

    ---

    All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

    ---